About Contact Us Careers

Albumin & Creatinine Tests Market Size and Forecast, by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), End-user (Hospital, Diagnostic & Research Labs) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 4665
  • Published Date: Nov 24, 2025
  • Report Format: PDF, PPT

Albumin & Creatinine Tests Market Outlook:

Albumin & Creatinine Tests Market size was valued at USD 5.65 billion in 2025 and is likely to cross USD 32.45 billion by 2035, registering more than 19.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of albumin & creatinine tests is assessed at USD 6.62 billion.

Albumin-Tests-Market -Creatinin-Tests Market-overview
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The growth of the market can be attributed to the increasing cases of kidney diseases and disorders worldwide. Kidney disease is a serious medical condition that can lead to kidney failure. As per the Centers for Disease Control and Prevention (CDC), more than 1 in 7 adults i.e., 37 million people, suffered from chronic kidney disease in 2021. A variety of urine analysis procedures and products are available to detect such disease, which include multiple kidney treatments as well as regular blood examinations of components such as creatinine, albumin, and the ACR ratio. Urine analysis can provide information about the presence of kidney diseases. It can also help to monitor the progression of kidney diseases and assess the effectiveness of treatment.

Additionally, other factors that are anticipated to contribute to the growth of the global albumin tests and creatinine tests market include the increasing awareness of early disease detection among people and the growing preference for home testing for regular monitoring. Additionally, innovations in urine analysis testing is anticipated to contribute to the growth of the market. For instance, Minuteful Kidney is a smartphone-based, home kidney function testing service that is convenient and affordable. The test is easy to use and can be done at home without visiting a doctor. It can be done regularly to help people with diabetes or high blood pressure monitor their kidney health. The result of the patient's test is automatically recorded in the app's electronic medical record, and it is automatically sent to their healthcare practitioner for further action.

Key Albumin & Creatinine Tests Market Insights Summary:

  • Regional Highlights:

    • By 2035, North America in the albumin tests & creatinine tests market is poised to lead the industry, supported by the escalating burden of chronic diseases and expanding healthcare expenditure across the population owing to rising diabetes and obesity cases.

  • Segment Insights:

    • Over 2026–2035, the urine albumin segment in the albumin tests & creatinine tests market is expected to dominate as demand strengthens, propelled by the rising proportion of patients undergoing urine albumin testing across age groups driven by growing preference for convenient and rapid diagnostic methods.
    • By 2035, the dipsticks & kits segment is projected to secure a substantial position, bolstered by the affordability and ease of use of testing kits impelled by faster turnaround times for urine-based diagnostics.

  • Key Growth Trends:

    • Rising Rates of Hypoalbuminemia and Hypovolemia
    • Increasing Prevalence of Chronic Disease Conditions

  • Major Challenges:

    • Increased Price of an Automated Analyzer
    • Lack of Accuracy of the Test

  • Key Players: Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers company, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.

Global Albumin & Creatinine Tests Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 5.65 billion
    • 2026 Market Size: USD 6.62 billion
    • Projected Market Size: USD 32.45 billion by 2035
    • Growth Forecasts: 19.1%

  • Key Regional Dynamics:

    • Largest Region: North America (By 2035)
    • Fastest Growing Region: North America
    • Dominating Countries: United States, Germany, China, Japan, United Kingdom
    • Emerging Countries: India, Brazil, South Korea, Mexico, Australia

    • Last updated on : 24 November, 2025

Growth Drivers

  • Rising Rates of Hypoalbuminemia and Hypovolemia – Hypoalbuminemia is one of the major factors associated with acute pancreatitis, and it is estimated that hypoalbuminemia affects 30% of patients with acute pancreatitis. In addition, low albumin levels are directly linked to an increased risk of severity and mortality associated with the condition. Thus, the level of serum albumin in the blood must be continually monitored. A continuous and frequent albumin test is required to monitor serum albumin levels. Hence, these factors are anticipated to lead to positive growth in the market.

  • Increasing Prevalence of Chronic Disease Conditions – The prevalence of chronic diseases leads to various kidney disorders, whose severity is assessed by two laboratory tests including creatinine levels and albumin levels in the urine. According to the World Health Organization, approximately 41 million people die every year from chronic diseases across the world, which accounts for 74% of all global deaths.

  • Rising Expenditure on Life Science and Medical Research – The United States Government spent more than USD 3 billion in 2019 on health research and development, with the global export value of medical technology products from the UK being nearly USD 5 billion in 2020. Rising expenditure on life science and medical research is creating opportunities for companies that provide integrated systems for albumin and creatinine tests. Increased funding for medical research is expected to drive the market’s growth.

  • Fast Growth in the Field of Diagnostics and Increasing Demand for Easy-to-use Kits – In India, the National Accreditation Board of Laboratories increased from 500 in 2015 to 1200 in 2020, which accounts for approximately 1% of total labs in India, as per the estimations. The number of accredited laboratories in various regions has increased rapidly in recent years, owing to the increasing demand for easy-to-use diagnostic kits.

  • Growing Geriatric Population and Increasing Practice of Sedentary Lifestyle – As per the World Health Organization, the worldwide old age population is estimated to double and reach 2.1 billion by 2050, from a base of 1 billion in 2020. The geriatric population is more susceptible to chronic diseases such as kidney disease. The sedentary lifestyle of this population group leads to further complications and health risks.

Challenges

  • Increased Price of an Automated Analyzer - Automatic analyzers analyze blood samples automatically and provide results within minutes. However, these machines are very expensive and require a great deal of maintenance. Therefore, many hospitals and clinics are unable to afford such devices and prefer to use semi-automated devices. The consequent impact on the adoption rate in developing countries with a large number of small hospitals is expected to hinder the market's growth.
  • Lack of Accuracy of the Test
  • Diagnostic and Analytical Difficulties with Urine Samples in Chronically Ill Individuals

Albumin & Creatinine Tests Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

19.1%

Base Year Market Size (2025)

USD 5.65 billion

Forecast Year Market Size (2035)

USD 32.45 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Albumin & Creatinine Tests Market Segmentation:

Type Segment Analysis

The global albumin & creatinine tests market is segmented and analyzed for demand and supply by type into blood & urine creatinine, urine albumin, and glycated albumin. Out of these, the urine albumin segment is estimated to gain the largest market share over the projected time frame. Albuminuria (urine albumin) is a sign of kidney disease and is characterized by excessive albumin levels in the urine. It has been observed that the proportion of patients who have urine albumin laboratory results is increasing over time in every age group, along with the resulting increase in consumer demand for convenient and rapid urine tests, which is expected to drive segment growth throughout the forecast period. As a result of a survey conducted in the United States between 2005 and 2019, it was found that the percentage of people with urine albumin results increased from 6%–16% among 40–49-year-olds; 11%–22% among 50–59-year-olds, 12%–27% among 60-69-year-olds and 10%–25% for those older than 70.

Product Segment Analysis

The global albumin & creatinine tests market is also segmented and analyzed for demand and supply by-product into analyzers, cartridges (POC, tabletop), dipsticks & kits, and reagents. Amongst these segments, the dipsticks & kits segment is expected to garner a significant share by the end of 2035. The albumin & creatinine tests are used to detect kidney damage, and the kits for these tests are becoming more popular as they are less expensive and easier to use than traditional analyzers and cartridges. Moreover, a urine dipstick test is a quick and easy way to test for the presence of various substances in the urine, such as protein, blood, and sugar. The results are usually available between 60 and 120 seconds after an appointment with the doctor. Therefore, such factors are expected to fuel the growth of the segment in the future.

Our in-depth analysis of the global market includes the following segments:

     By Product
  • Analyzers
  • Cartridges (PoC, Tabletop)
  • Dipsticks & Kits
  • Reagents

       By Type
  • Blood & Urine Creatinine
  • Urine Albumin
  • Glycated Albumin

       By End User
  • Hospital
  • Diagnostic & Research Labs
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Albumin & Creatinine Tests Market - Regional Analysis

North American Market Insights

North America industry is set to account for largest revenue share by 2035. Growth in the regional market can be attributed primarily to the increasing prevalence of chronic diseases and the rise in healthcare spending by the general population. Furthermore, chronic diseases such as type 1 or type 2 diabetes, high blood pressure, and obesity can lead to kidney diseases. With the growing incidence of these diseases, rapid urine testing has become an increasingly crucial method of diagnosing kidney disorders. The prevalence of obesity, a chronic disease condition, in the U.S. from 2017 to 2020 rose from 30.5% to 41.9% and in the same period, the prevalence of severe obesity rose from 4.7% to 9.2%, as per the Centers for Disease Control and Prevention. Additionally, according to the same source, more than 37 million Americans suffer from diabetes, with approximately 90-95% having diabetes type 2 most commonly occurs in adults over 45.

Albumin and Creatinine Tests Market Trends
Get Strategic Analysis by Region Now: Request Free Sample PDF

Albumin & Creatinine Tests Market Players:

    • RayBiotech Life, Inc.

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Danaher Corporation
    • FUJIFILM Wako Pure Chemical Corporation
    • Nova Biomedical
    • Ortho Clinical Diagnostics
    • PromoCell GmbH
    • Siemens Healthineers company
    • Sysmex Corporation
    • Teco Diagnostics
    • Thermo Fisher Scientific Holdings, Inc.

Recent Developments

  • Sysmex Corporation introduced a new product named as UF-1500 Fully Automated Urine Particle Analyzer (UF-1500). The UF-1500 is a new product that automates the process of testing urine sediments. This will allow for faster and more accurate results.

  • Siemens Healthcare GmbH declared the global OEM partnership to enhance patient monitoring with chronic kidney diseases. Using Healthy. Io's smartphone-based urinalysis system, the company's urinalysis reagents allow patients to conduct home testing

  • Report ID: 4665
  • Published Date: Nov 24, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of albumin & creatinine tests is assessed at USD 6.62 billion.

The global albumin & creatinine tests market size was valued at more than USD 5.65 billion in 2025 and is expected to register a CAGR of over 19.1%, exceeding USD 32.45 billion revenue by 2035.

Key players in the market include Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers company, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.

Albumin & Creatinine Tests Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos